Change in Alzheimer's Drug Vial Size Could Be Big Money-Saver for Medicare

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 14, 2024.

By Dennis Thompson HealthDay Reporter

MONDAY, Oct. 14, 2024 -- A simple tweak in available vial sizes of the breakthrough Alzheimer’s drug Leqembi could save Medicare hundreds of millions of dollars each year, a new analysis claims.

About 6% of Leqembi (lecanemab) is discarded because patients are frequently prescribed doses lower than the size of the drug’s single-use vials.

This waste costs Medicare about $1,600 a patient every year, researchers estimated in a report published Oct. 14 in the journal JAMA Internal Medicine.

Making a 75-milligram vial available alongside the two current options of 200 milligrams and 500 milligrams could save Medicare up to 74% of the money lost from discarded Leqembi -- as much as $336 million a year.

“It is imperative to reduce spending on services that do not improve the health of patients, and this is a prime example of such, given that Medicare is paying for a drug only to literally throw part of it away,” said lead researcher Frank Zhou, a fourth-year medical student at the David Geffen School of Medicine at UCLA.

Medicare patients can be prescribed Leqembi if they’ve been diagnosed with mild cognitive impairment or mild Alzheimer’s disease and their doctor agrees to participating in ongoing data gathering regarding the drug’s effectiveness.

Prior estimates have held that Leqembi treatment could cost Medicare $2 billion to $5 billion a year, based on the number of people eligible for the drug.

Leqembi is administered based on a person’s body weight. For this study, researchers estimated how many Medicare patients are available to receive Leqembi, then calculated each person’s estimated dose.

The results showed that a lot of the drug is thrown out to make a person’s recommended dose match the vial sizes available to doctors.

For example, a 165-pound patient would be prescribed a 650-milligram dose, researchers said.

Doctors would draw that amount from one 500-milligram and one 200-milligram vial, and the remaining 50 milligrams of drug would be tossed out, researchers said.

That amounts to an estimated $133 million to $336 million worth of Leqembi thrown away every year, researchers said.

In essence, the discarded Leqembi from 16 patients could provide enough medication for an additional person, researchers found.

Adding a third 75-milligram vial could reduce that waste by 74% without harming quality of care or causing a drug price increase, the team concluded.

This sort of analysis could be helpful for many other drugs covered by Medicare, researchers noted.

“There are significant opportunities for savings even with this single drug, implying that even greater savings could be achieved if our proposed solutions were applied to other infused therapies,” Zhou said in a UCLA news release.

Sources

  • UCLA, news release, Oct. 14, 2024

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2024-10-15 06:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords